164 related articles for article (PubMed ID: 23206972)
1. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.
Lee TF; Chao PJ; Wang HY; Hsu HC; Chang P; Chen WC
BMC Cancer; 2012 Dec; 12():567. PubMed ID: 23206972
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
3. Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.
Moiseenko V; Wu J; Hovan A; Saleh Z; Apte A; Deasy JO; Harrow S; Rabuka C; Muggli A; Thompson A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1108-14. PubMed ID: 21640505
[TBL] [Abstract][Full Text] [Related]
4. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.
Liu M; Moiseenko V; Agranovich A; Karvat A; Kwan W; Saleh ZH; Apte AA; Deasy JO
Acta Oncol; 2010 Oct; 49(7):1040-4. PubMed ID: 20831493
[TBL] [Abstract][Full Text] [Related]
5. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
[TBL] [Abstract][Full Text] [Related]
6. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
[TBL] [Abstract][Full Text] [Related]
7. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
Semenenko VA; Li XA
Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
[TBL] [Abstract][Full Text] [Related]
8. NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation.
Mavroidis P; Pearlstein KA; Moon DH; Xu V; Royce TJ; Weiner AA; Shen CJ; Marks LB; Chera BS; Das SK; Wang K
Radiat Oncol; 2021 Mar; 16(1):56. PubMed ID: 33743773
[TBL] [Abstract][Full Text] [Related]
9. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
[TBL] [Abstract][Full Text] [Related]
10. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships.
Roesink JM; Moerland MA; Hoekstra A; Van Rijk PP; Terhaard CH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1451-60. PubMed ID: 15050323
[TBL] [Abstract][Full Text] [Related]
12. Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose.
Ong ALK; Knight K; Panettieri V; Dimmock M; Tuan JKL; Tan HQ; Wright C
Front Oncol; 2022; 12():1084311. PubMed ID: 36591496
[TBL] [Abstract][Full Text] [Related]
13. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.
Wang Z; Chen M; Sun J; Jiang S; Wang L; Wang X; Sahoo N; Gunn GB; Frank SJ; Nguyen QN; Liao Z; Chang JY; Zhu XR; Zhang X
Radiother Oncol; 2020 May; 146():200-204. PubMed ID: 32220701
[TBL] [Abstract][Full Text] [Related]
14. Parotid gland function after radiotherapy: the combined michigan and utrecht experience.
Dijkema T; Raaijmakers CP; Ten Haken RK; Roesink JM; Braam PM; Houweling AC; Moerland MA; Eisbruch A; Terhaard CH
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):449-53. PubMed ID: 20056347
[TBL] [Abstract][Full Text] [Related]
15. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
Eisbruch A; Ten Haken RK; Kim HM; Marsh LH; Ship JA
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):577-87. PubMed ID: 10524409
[TBL] [Abstract][Full Text] [Related]
16. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines.
Owosho AA; Thor M; Oh JH; Riaz N; Tsai CJ; Rosenberg H; Varthis S; Yom SH; Huryn JM; Lee NY; Deasy JO; Estilo CL
J Craniomaxillofac Surg; 2017 Apr; 45(4):595-600. PubMed ID: 28256385
[TBL] [Abstract][Full Text] [Related]
17. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
[TBL] [Abstract][Full Text] [Related]
18. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence.
Marzi S; Pinnarò P; D'Alessio D; Strigari L; Bruzzaniti V; Giordano C; Giovinazzo G; Marucci L
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):e54-62. PubMed ID: 22138192
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
20. Estimating the Dose-Response Relationship for Ocular Pain after Radiotherapy of Head and Neck Cancers and Skull Base Tumors based on the LKB Radiobiological Model.
Momeni N; Broomand MA; Roozmand Z; Hamzian N
J Biomed Phys Eng; 2023 Oct; 13(5):411-420. PubMed ID: 37868939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
